For research use only. Not for therapeutic Use.
Urabrelimab（Cat No.:I042130）is an investigational monoclonal antibody designed to target and block the TIM-3 (T-cell immunoglobulin and mucin-domain containing-3) receptor, which plays a key role in suppressing immune responses, particularly in the tumor microenvironment. By inhibiting TIM-3, urabrelimab aims to enhance T-cell activity, allowing the immune system to better recognize and attack cancer cells. It is being studied in clinical trials for the treatment of various cancers, including non-small cell lung cancer and solid tumors. Ongoing research evaluates its safety, efficacy, and potential benefits when combined with other immunotherapies.
| Catalog Number | I042130 |
| CAS Number | 2249722-58-3 |
| Purity | ≥95% |
